SNAIDs were documented as the exclusive cause of ulcers in 11.5% of the patients, but were also used by 29.8% of the patients with H. pylori infections. 14.4% of the cases corresponded to ulcers which were negative for both H. pylori and NSAIDs use.
El tratamiento contra el H. pylori repercute directamente en la curación de la úlcera péptica, por esta razón se incluye como una de las indicaciones mandatorias de erradicación 1, 2.